ARTICLE | Distillery Techniques
Drug platforms
July 18, 2018 3:41 PM UTC
A non-viral CRISPR-Cas9-based method for engineering patient-derived T cells could be used to generate personalized cell therapies for cancer and autoimmune diseases. The method consists of co-electro...
BCIQ Company Profiles